At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 70 enrolled
Drug / intervention
Solifenacin +1 moredrug
Likely dose
Solifenacin 5mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of the Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With OAB: A Prospective Randomized Multicenter Study
In Brief
A Phase 4 clinical trial evaluating Solifenacin and Solifenacin plus Tamsulosin for Overactive Bladder. Completed, enrolled 70 participants across 1 site.
Detailed Summary
The aim of the study is to investigate if the combination therapy consisting of anticholinergics plus alpha-blockers could be beneficial for women suffering from Overactive Bladder (OAB).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOveractive Bladder
CountriesSouth Korea
Collaborators--
Timeline
Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2010
First PostedFeb 2012
Primary CompletionDec 2013
Study CompletionFeb 2014
TodayJul 2026
First PostedFeb 15, 2012
Enrollment StartDec 1, 2010
Primary CompletionDec 1, 2013
Study CompletionFeb 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 14.4 years ago
Interventions
Solifenacindrug
Solifenacin (5mg, qd, oral)
Solifenacin plus Tamsulosindrug
Solifenacin (5mg, qd, oral) plus Tamsulosin (0.2mg, qd, oral)